Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Salix Pharmaceuticals, Ltd. (SLXP) Q4 Earnings Preview: Declining Sales Of Xifaxan As Valeant Deal Looms
Salix Pharmaceuticals, Ltd. (SLXP) Q4 Earnings Preview: Declining Sales Of Xifaxan As Valeant Deal Looms
Salix Pharmaceuticals, Ltd. (SLXP) Q4 Earnings Preview: Declining Sales Of Xifaxan As Valeant Deal Looms
Submitted by
admin
on March 2, 2015 - 4:38pm
Source:
Bidness Etc.
News Tags:
Salix
earnings
Xifaxan
Valeant Pharmaceuticals
M&A
Headline:
Salix Pharmaceuticals, Ltd. (SLXP) Q4 Earnings Preview: Declining Sales Of Xifaxan As Valeant Deal Looms
Do Not Allow Advertisers to Use My Personal information
